Google Plus Facebook LinkedIn Twitter Vimeo RSS

Unilife receives patent for Unifill syringe

By , - Last modified: July 13, 2012 at 9:56 AM

York County-based Unilife Corp. has received a U.S. patent for its Unifill syringe that provides a long-term competitive advantage into 2026, according to a news release.

It covers the firm's proprietary technology for the integration of automatic and operator-controlled needle retraction features within the barrel of a prefilled syringe, the release stated.

Getting the patent is further validation of the uniqueness of Unilife's technology, the company said.

The safety syringe maker recently announced it signed a seven-year commercial supply contract with a pharmaceutical company for the Unifill syringe.

Shares of the company are traded on the Nasdaq under the ticker symbol UNIS.

More From This Industry

Write to the Editorial Department at

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy